Nantahala Capital Management, LLC

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 1472322 New Canaan, CT

Position in ZVRA

as of Jun 30, 2026 · filed Aug 19, 2026 Compact

Position Value

$25,775,805

+$2,271,362 QoQ

Shares Held

1,797,476

-28.7% QoQ

Ownership

3.03%

of shares outstanding

% of Portfolio

1.57%

of 13F equity value

Holder Rank

of 157 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Nantahala Capital Management, LLC holds $620,287,047 across 52 Biotechnology names. ZVRA ranks #5 (4.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SVRA	Savara Inc	6,976,810	$42,977,149
2	AVTX	Avalo Therapeutics, Inc.	1,862,250	$34,414,380
3	LBRX	Lb Pharmaceuticals Inc	1,052,894	$34,171,674
4	ABEO	Abeona Therapeutics Inc.	5,136,490	$31,743,508
5	ZVRA	Zevra Therapeutics, Inc. This page	1,797,476	$25,775,805
6	MLYS	Mineralys Therapeutics, Inc.	820,481	$22,136,577
7	QURE	uniQure N.V.	455,660	$20,987,699
8	AURA	Aura Biosciences, Inc.	2,951,030	$20,952,313

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$25,775,805	1,797,476	-28.7%	Shares	Sole	2026-08-19
2026-03-31	$23,504,443	2,521,936	+42.3%	Shares	Sole	2026-05-15
2025-12-31	$15,876,546	1,771,936	-10.1%	Shares	Sole	2026-02-13
2025-09-30	$18,753,111	1,971,936	+34.0%	Shares	Sole	2025-11-14
2025-06-30	$12,967,756	1,471,936	0.0%	Shares	Sole	2025-08-14
2025-03-31	$11,024,800	1,471,936	-37.1%	Shares	Sole	2025-05-15
2024-12-31	$19,518,377	2,340,333	-20.0%	Shares	Sole	2025-02-14
2024-09-30	$20,292,705	2,924,021	+20.9%	Shares	Sole	2024-11-14
2024-06-30	$11,855,231	2,419,435	-1.4%	Shares	Sole	2024-08-14
2024-03-31	$14,229,749	2,453,405	0.0%	Shares	Sole	2024-05-15
2023-12-31	$16,069,802	2,453,405	+6.3%	Shares	Sole	2024-02-14
2023-09-30	$11,125,601	2,308,216	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.